HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.

AbstractOBJECTIVES:
We examined interrelationships between chemokine C-C motif ligand 2 (CCL2) genotype and expression of inflammatory markers in the cerebrospinal fluid (CSF), plasma viral load, CD4 cell count and neurocognitive functioning among HIV-infected adults. We hypothesized that HIV-positive carriers of the 'risk' CCL2 -2578G allele, caused by a single nucleotide polymorphism (SNP) at rs1024611, would have a higher concentration of CCL2 in CSF, and that CSF CCL2 would be associated with both higher concentrations of other proinflammatory markers in CSF and worse neurocognitive functioning.
DESIGN:
A cross-sectional study of 145 HIV-infected individuals enrolled in the National NeuroAIDS Tissue Consortium cohort for whom genotyping, CSF and neurocognitive data were available.
METHODS:
Genomic DNA was extracted from peripheral blood mononuclear cells and/or frozen tissue specimens. CSF levels of CCL2, interleukin (IL)-2, IL-6, tumour necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), soluble tumor necrosis factor receptor 2, sIL-6Rα, sIL-2, sCD14 and B-cell activating factor were quantified. Neurocognitive functioning was measured using a comprehensive battery of neuropsychological tests.
RESULTS:
Carriers of the CCL2 -2578G allele had a significantly higher concentration of CCL2 in CSF. CSF CCL2 level was positively and significantly associated with other CSF neuroinflammatory markers and worse cognitive functioning. There was a significant association between genotype and plasma viral load, such that carriers of the CCL2 -2578G allele with high viral load expressed greater levels of CCL2 and had higher neurocognitive deficit scores than other genotype/viral load groups.
CONCLUSION:
Individuals with the CCL2 -2578G allele had higher levels of CCL2 in CSF, which was associated with increased pro-inflammatory markers in CSF and worse neurocognitive functioning. The results highlight the potential role of intermediate phenotypes in studies of genotype and cognition.
AuthorsApril D Thames, Marisa S Briones, Larry I Magpantay, Otoniel Martinez-Maza, Elyse J Singer, Charles H Hinkin, Susan Morgello, Benjamin B Gelman, David J Moore, Keith Heizerling, Andrew J Levine
JournalAIDS (London, England) (AIDS) Vol. 29 Issue 12 Pg. 1483-91 (Jul 31 2015) ISSN: 1473-5571 [Electronic] England
PMID26244388 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • CCL2 protein, human
  • Chemokine CCL2
  • Cytokines
Topics
  • AIDS Dementia Complex (pathology)
  • Adolescent
  • Adult
  • CD4 Lymphocyte Count
  • Cerebrospinal Fluid (chemistry)
  • Chemokine CCL2 (genetics)
  • Cross-Sectional Studies
  • Cytokines (cerebrospinal fluid)
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • HIV Infections (pathology)
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Plasma (virology)
  • Viral Load
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: